Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Effect of a Palonosetron on Blood Coagulation
NCT04507711Unknown
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Sep 2020
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of palonosetron (4 arms), sponsored by Seoul National University Bundang Hospital. Primary endpoint: Citrated Functional Fibrinogen at 1 hour. Status: unknown.
02
Drugs
palonosetron
Beyond the preview
Go deeper on NCT04507711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04507711.